A multimodal dataset for precision oncology in head and neck cancer

Marion Dörrich1, Matthias Balk2,3, Tatjana Heusinger2,4

  • 1Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Nature Communications
|August 4, 2025
PubMed

Insights

A new multimodal dataset, HANCOCK, aids head and neck cancer research. Combining diverse patient data with machine learning improves treatment predictions, advancing precision oncology.

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning

Background:

  • Head and neck cancer presents a significant clinical challenge with poor patient prognoses.
  • Personalized treatment strategies hold promise for improving outcomes but are hindered by limited public data.
  • Existing research lacks comprehensive, multimodal datasets for head and neck cancer.

Purpose of the Study:

  • To introduce the HANCOCK dataset, a novel multimodal resource for head and neck cancer research.
  • To facilitate the exploration of head and neck cancer pathology and treatment response using integrated data.
  • To advance multimodal machine learning methodologies in the field of precision oncology.

Main Methods:

  • Development of the HANCOCK dataset, a monocentric collection of real-world data from 763 head and neck cancer patients.
  • Inclusion of diverse data modalities: demographical, pathological, blood data, surgery reports, and histologic images.
  • Application of machine learning techniques, including foundation models for imaging data, for endpoint prediction.

Main Results:

  • Demonstration that combining multiple data modalities via machine learning outperforms single-modality approaches for endpoint prediction.
  • Validation of the utility of integrating imaging data with foundation models to enhance predictive accuracy.
  • Establishment of a low-dimensional representation for exploring the multimodal HANCOCK dataset.

Conclusions:

  • The HANCOCK dataset provides a valuable resource for advancing head and neck cancer research.
  • Multimodal data integration and machine learning significantly improve prediction of clinical endpoints in head and neck cancer.
  • HANCOCK is poised to drive innovation in precision oncology and multimodal learning research.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K